Spots Global Cancer Trial Database for relapsed solid tumor
Every month we try and update this database with for relapsed solid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma | NCT03690869 | Relapsed Solid ... Refractory Soli... Relapsed Centra... Refractory Cent... Diffuse Intrins... High Grade Glio... | cemiplimab (mon... cemiplimab (mai... Conventional or... Re-irradiation | - 25 Years | Regeneron Pharmaceuticals | |
| APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors | NCT03053466 | Solid Tumor Microsatellite ... Mismatch Repair... Cancer of Unkno... | APL-501 | 18 Years - | Apollomics (Australia) Pty. Ltd. | |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma | NCT04238819 | Relapsed Solid ... Refractory Soli... | Abemaciclib Irinotecan Temozolomide Dinutuximab GM-CSF | - 21 Years | Eli Lilly and Company | |
| Safety and Tolerability of Intravenous Administration of ICVB-1042 | NCT05904236 | Patients With A... | Treatment with ... | 18 Years - | IconOVir Bio | |
| APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors | NCT03053466 | Solid Tumor Microsatellite ... Mismatch Repair... Cancer of Unkno... | APL-501 | 18 Years - | Apollomics (Australia) Pty. Ltd. | |
| Safety and Tolerability of Intravenous Administration of ICVB-1042 | NCT05904236 | Patients With A... | Treatment with ... | 18 Years - | IconOVir Bio | |
| Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors | NCT04809012 | Solid Tumor Refractory Tumo... Relapsed Solid ... | STI-3031 | 18 Years - | Sorrento Therapeutics, Inc. | |
| Oxaliplatin for Children With Solid Tumors | NCT01558453 | Relapsed Solid ... Refractory Soli... | Oxaliplatin | - 21 Years | Hospital Santa Marcelina | |
| VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors | NCT04796012 | Solid Tumor Rhabdomyosarcom... | Atezolizumab Vincristine Irinotecan Temozolomide | 6 Months - 18 Years | University of Texas Southwestern Medical Center | |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma | NCT03690869 | Relapsed Solid ... Refractory Soli... Relapsed Centra... Refractory Cent... Diffuse Intrins... High Grade Glio... | cemiplimab (mon... cemiplimab (mai... Conventional or... Re-irradiation | - 25 Years | Regeneron Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
